H-CDCRGDCFC-OH

Ref. 3D-PP43888

Informations sur le produit

• Nom: H-CDCRGDCFC-OH
• Synonymes: NH2-Cys-Asp-Cys-Arg-Gly-Asp-Cys-Phe-Cys-OH

Description

Peptide H-CDCRGDCFC-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-CDCRGDCFC-OH include the following: Functional peptide-based drug delivery systems Z Lian, T Ji - Journal of Materials Chemistry B, 2020 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2020/z3/d0tb00713g Preparation and characterization of RGD tumour-homing-peptide-modified plasminogen K5 Y Wang , Z Guo, Q Ge, E Wang - Biotechnology and , 2010 - Wiley Online Libraryhttps://iubmb.onlinelibrary.wiley.com/doi/abs/10.1042/BA20100225 Dual-drug RGD conjugates provide enhanced cytotoxicity to melanoma and non-small lung cancer cells Y Gilad , E Noy, H Senderowitz , A Albeck - Peptide , 2016 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/bip.22800 Potential tumor-targeting peptide vector of histidylated oligolysine conjugated to a tumor-homing RGD motif Y Aoki, S Hosaka, S Kawa, K Kiyosawa - Cancer gene therapy, 2001 - nature.comhttps://www.nature.com/articles/7700362 Non-cationic RGD-containing protein carrier for tumor-targeted siRNA delivery X Yu, L Xue, J Zhao, S Zhao, D Wu, HY Liu - 2021 - researchsquare.comhttps://www.researchsquare.com/article/rs-643092/latest The use of one-bead one-compound combinatorial library technology to discover high-affinity alphavbeta3 integrin and cancer targeting arginine-glycine-aspartic acid ligands W Xiao, Y Wang, EY Lau, J Luo , N Yao, C Shi - Molecular cancer , 2010 - AACRhttps://aacrjournals.org/mct/article-abstract/9/10/2714/93729 Tumor Targeting Peptides for Cytotoxic, Chemotherapy Delivery W Arap, BURNHAM INST LA JOLLA CA - 1999., 1999 - apps.dtic.milhttps://apps.dtic.mil/sti/citations/tr/ADA384033 Gd-EDDA/HYNIC-RGD as an MR molecular probe imaging integrin alphaΜbeta3 receptor-expressed tumor-MR molecular imaging of angiogenesis T Huo, X Du, S Zhang, X Liu, X Li - European journal of radiology, 2010 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0720048X08006542 Leucine-aspartic acid-valine sequence as targeting ligand & drug carrier for doxorubicin delivery to melanoma cells S Zhong - 2009 - search.proquest.comhttps://search.proquest.com/openview/812a7e17563493dd89c1ce6af68241b7/1?pq-origsite=gscholar&cbl=18750 Preparation and Functional Evaluation of RGD-Modified Proteins as alphavbeta3 Integrin Directed Therapeutics RJ Kok , AJ Schraa, EJ Bos, HE Moorlag - Bioconjugate , 2002 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/bc015561+ Modularly assembled magnetite nanoparticles enhance in vivo targeting for magnetic resonance cancer imaging PC Wu, CH Su , FY Cheng, JC Weng - Bioconjugate , 2008 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/bc800092w Self-assembling peptides: potential role in tumor targeting P Sadatmousavi , M Soltani , R Nazarian - Current , 2011 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cpb/2011/00000012/00000008/art00002 Peptides for tumor-specific drug targeting: State of the art and beyond M Roveri, M Bernasconi , JC Leroux - Journal of materials , 2017 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2017/tb/c7tb00318h Small molecule toxins targeting tumor receptors M Dyba, NI Tarasova - Current pharmaceutical , 2004 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cpd/2004/00000010/00000019/art00004 Engineered protein nanoparticles for in vivo tumor detection KY Ahn, HK Ko, BR Lee, EJ Lee , JH Lee, Y Byun - Biomaterials, 2014 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0142961214004396 Peptide-mediated gene transfer of cationic lipid/plasmid DNA complexes to endothelial cells K Anwer, G Kao, A Rolland, WHP Driessen - Journal of drug , 2004 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/10611860410001724468 Small molecule-and peptide-drug conjugates addressing integrins: A story of targeted cancer treatment J Paulus, N Sewald - Journal of Peptide Science, 2024 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/psc.3561 Expression, purification, and characterization of a neovasculature targeted rmhTNF-alpha in Escherichia coli H Wang, Z Yan, J Shi, W Han, Y Zhang - Protein expression and purification, 2006 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1046592805001828 Design, synthesis, and biological evaluation of a dual tumor-specific motive containing integrin-targeted plasmin-cleavable doxorubicin prodrug FMH De Groot, HJ Broxterman, HPHM Adams - Molecular cancer , 2002 - AACRhttps://aacrjournals.org/mct/article-abstract/1/11/901/234301 Coupling Tumor Necrosis Factor-alpha with alphaV Integrin Ligands Improves Its Antineoplastic Activity F Curnis , A Gasparri, A Sacchi, R Longhi, A Corti - Cancer research, 2004 - AACRhttps://aacrjournals.org/cancerres/article-abstract/64/2/565/511882 Tumor targeting with RGD peptide ligands-design of new molecular conjugates for imaging and therapy of cancers E Garanger, D Boturyn, P Dumy - Anti-Cancer Agents in , 2007 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/acamc/2007/00000007/00000005/art00007 The disulfide bond of an RGD4C motif inserted within the Hi loop of the adenovirus type 5 fiber protein is critical for retargeting to alphav-integrins D Majhen , J Richardson, B Vukelić - The Journal of Gene , 2012 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/jgm.2686 A new phage-display tumor-homing peptide fused to antiangiogenic peptide generates a novel bioactive molecule with antimelanoma activity AL Matsuo, MA Juliano , CR Figueiredo - Molecular Cancer , 2011 - AACRhttps://aacrjournals.org/mcr/article-abstract/9/11/1471/90739 Peptide-based strategies for targeted tumor treatment and imaging A Ayo, P Laakkonen - Pharmaceutics, 2021 - mdpi.comhttps://www.mdpi.com/1999-4923/13/4/481

• Marque: Biosynth